New shot in the eye aims to halt leading cause of blindness
NCT ID NCT06672536
Summary
This study is testing a new drug called SCT520FF, given as an injection into the eye, for people with 'wet' age-related macular degeneration (AMD). The main goals are to find a safe dose and see if it helps improve or stabilize vision. Researchers will enroll about 82 patients to test different dose levels and monitor for side effects and changes in eyesight.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NAMD are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Tianjin Medical University Eye Hospital
RECRUITINGTianjing, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.